Who owns PASITHEA THERAPEUTICS CORP?

Tip: Access positions for across all investors

Analyze quarterly positions in Pasithea Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pasithea Therapeutics Corp stock

Who bought or sold PASITHEA THERAPEUTICS CORP this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
AdvisorShares Investments 258k $186k 33% Sep 2025
 View chart
Citadel Advisors 67k $49k 44% Sep 2025
 View chart
Vanguard Group 54k $39k 100% Sep 2025
 View chart
Two Sigma Investments 36k $26k 100% Sep 2025
 View chart
XTX Topco 34k $25k 100% Sep 2025
 View chart
Renaissance Technologies 31k $23k 100% Sep 2025
 View chart
Geode Capital Management 26k $18k 100% Sep 2025
 View chart
Virtu Financial 25k $18k 100% Sep 2025
 View chart
Jane Street 25k $18k 100% Sep 2025
 View chart
Two Sigma Securities 21k $15k 100% Sep 2025
 View chart
UBS Group 18k $14k -56% Sep 2025
 View chart
Hrt Financial 11k $7.0k 100% Sep 2025
 View chart
Hurley Capital 3.7k $2.7k 0% Sep 2025
 View chart
Tower Research Capital 1.2k $890.965700 -3% Sep 2025
 View chart
SBI Securities 1.1k $769.016700 0% Sep 2025
 View chart
Royal Bank of Canada 250.00 $0 0% Sep 2025
 View chart
Jpmorgan Chase & Co 150.00 $108.000000 0% Sep 2025
 View chart

Who sold out of Pasithea Therapeutics Corp?

Fund or Company Name Date Sold Shares Held Valued At
LPL Financial Jun 2025 10k $7.2k
Raymond James Financial Jun 2025 1.6k $1.1k